MyHep All Tablet (Sofosbuvir + Velpatasvir) used to treat chronic hepatitis C infection

Precaution

Important Precaution Points

• Chronic hepatitis C affects liver function, so ongoing liver monitoring is important throughout the treatment period.

• In advanced liver conditions, response to therapy may vary and requires careful evaluation of progress.

• Co-existing viral infections such as hepatitis B or HIV may require a combined treatment approach for safe outcomes.

• During pregnancy or breastfeeding, treatment decisions depend on careful assessment of potential risks and benefits.

• Any previous intolerance or adverse reaction to antiviral therapy should be reviewed before starting this medicine.

• Regular monitoring helps track viral response and supports safer long-term outcomes.

Usages

MyHep All Tablet is taken orally as part of a structured antiviral treatment plan. It works continuously in the body to suppress hepatitis C virus activity and improve treatment response over time.

How It Is Used

▸ Oral daily intake: Taken once daily with water at a consistent time for stable antiviral effect
▸ Blocks viral activity: Stops hepatitis C virus replication by interfering with essential viral proteins
▸ Continuous treatment course: Must be taken regularly throughout the full treatment period for best results
▸ Combination treatment use: May be combined with other antiviral medicines depending on infection type and severity
▸ Complete course importance: Stopping early may reduce treatment success and allow viral return
▸ Regular monitoring support: Periodic evaluation of liver function and viral response helps track improvement
▸ Specific viral action only: Works only against hepatitis C virus and does not treat other infections

Uses

MyHep All Tablet (Sofosbuvir + Velpatasvir) is used for the treatment of chronic hepatitis C virus infection. It works by directly acting on the virus, stopping it from multiplying .

Key Uses

▸ Chronic hepatitis C management: Helps control long-term hepatitis C infection by reducing viral activity in the bloodstream
▸ Viral replication control: Blocks hepatitis C virus from multiplying by targeting key viral enzymes
▸ Liver protection support: Helps reduce ongoing liver damage caused by active viral infection
▸ Viral load reduction: Helps decrease the number of hepatitis C virus particles in the body over time
▸ Combination antiviral action: Works through dual mechanisms for stronger and more complete viral suppression
▸ Long-term infection control: Supports sustained improvement in liver condition when used for full treatment duration

SIDE EFFECTS

Common Side Effects

• Headache: Mild headache due to body adjustment during antiviral therapy

• Fatigue: Feeling of tiredness or low energy during treatment course

• Nausea: Mild stomach discomfort or feeling of sickness

• Insomnia: Difficulty in sleeping or disturbed sleep patterns

• Weakness: General body weakness during early phase of treatment

Less Common Side Effects

• Diarrhea: Loose stools in some individuals during therapy

• Irritability: Mild mood changes or restlessness

• Dizziness: Temporary lightheadedness

• Loss of appetite: Reduced desire to eat during treatment

• Muscle pain: Mild body aches or discomfort

Serious Side Effects